Entry |
|
Name |
L-Cysteine;
L-2-Amino-3-mercaptopropionic acid
|
Formula |
C3H7NO2S
|
Exact mass |
121.0197
|
Mol weight |
121.1582
|
Structure |

|
Remark |
|
Reaction |
|
Pathway |
map00260 | Glycine, serine and threonine metabolism |
map00270 | Cysteine and methionine metabolism |
map00311 | Penicillin and cephalosporin biosynthesis |
map00430 | Taurine and hypotaurine metabolism |
map00770 | Pantothenate and CoA biosynthesis |
map01060 | Biosynthesis of plant secondary metabolites |
map01110 | Biosynthesis of secondary metabolites |
map01120 | Microbial metabolism in diverse environments |
map04974 | Protein digestion and absorption |
map05230 | Central carbon metabolism in cancer |
|
Module |
M00021 | Cysteine biosynthesis, serine => cysteine |
M00338 | Cysteine biosynthesis, homocysteine + serine => cysteine |
M00609 | Cysteine biosynthesis, methionine => cysteine |
M00672 | Penicillin biosynthesis, aminoadipate + cycteine + valine => penicillin |
M00673 | Cephamycin C biosynthesis, aminoadipate + cycteine + valine => cephamycin C |
|
Enzyme |
|
Brite |
Compounds with biological roles [BR:br08001]
Peptides
Amino acids
Common amino acids
C00097 Cysteine (Cys)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D00026 L-Cysteine (JP17)
Classification of Japanese OTC drugs [BR:br08313]
Nourishing tonics and health supplements
45 Protein and amino acid based drugs
D00026 L-Cysteine (JP17)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
L-Cysteine
D00026 L-Cysteine (JP17)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00026 L-Cysteine
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 7
1 C1c C 24.5141 -15.4370
2 C6a C 23.3459 -14.6895
3 C1b C 25.7289 -14.7361
4 N1a N 24.5609 -16.8388
5 O6a O 22.1311 -15.3436
6 O6a O 23.3459 -13.2877
7 S1a S 26.9438 -15.4838
BOND 6
1 1 2 1
2 1 3 1
3 1 4 1 #Down
4 2 5 1
5 2 6 2
6 3 7 1
|